Jazz Pharmaceuticals Plc Stock Price Prediction
| JAZZ Stock | USD 122.64 0.15 0.12% |
Oversold Vs Overbought
75
Oversold | Overbought |
Quarterly Earnings Growth 0.597 | EPS Estimate Next Quarter 6.07 | EPS Estimate Current Year 20.1799 | EPS Estimate Next Year 21.8294 | Wall Street Target Price 177.5263 |
Using Jazz Pharmaceuticals hype-based prediction, you can estimate the value of Jazz Pharmaceuticals PLC from the perspective of Jazz Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Jazz Pharmaceuticals PLC Hype to Price Pattern
Investor biases related to Jazz Pharmaceuticals' public news can be used to forecast risks associated with an investment in Jazz. The trend in average sentiment can be used to explain how an investor holding Jazz can time the market purely based on public headlines and social activities around Jazz Pharmaceuticals PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Jazz Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Jazz Pharmaceuticals.
The fear of missing out, i.e., FOMO, can cause potential investors in Jazz Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Jazz because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Jazz Pharmaceuticals after-hype prediction price | USD 122.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Jazz |
Jazz Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Jazz Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Jazz Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Jazz Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Jazz Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Jazz Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Jazz Pharmaceuticals' historical news coverage. Jazz Pharmaceuticals' after-hype downside and upside margins for the prediction period are 120.24 and 124.38, respectively. We have considered Jazz Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Jazz Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Jazz Pharmaceuticals PLC is based on 3 months time horizon.
Jazz Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Jazz Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Jazz Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Jazz Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 2.08 | 0.30 | 0.00 | 10 Events / Month | 16 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
122.64 | 122.31 | 0.27 |
|
Jazz Pharmaceuticals Hype Timeline
Jazz Pharmaceuticals PLC is currently traded for 122.64. The entity has historical hype elasticity of -0.3, and average elasticity to hype of competition of 0.0. Jazz is forecasted to decline in value after the next headline, with the price expected to drop to 122.31. The average volatility of media hype impact on the company price is about 76.19%. The price decrease on the next news is expected to be -0.27%, whereas the daily expected return is currently at 0.11%. The volatility of related hype on Jazz Pharmaceuticals is about 19066.67%, with the expected price after the next announcement by competition of 122.64. About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. Jazz Pharmaceuticals PLC has Price/Earnings To Growth (PEG) ratio of 0.92. The entity recorded earning per share (EPS) of 7.06. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Jazz Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Jazz Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Jazz Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Jazz Pharmaceuticals' future price movements. Getting to know how Jazz Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Jazz Pharmaceuticals may potentially react to the hype associated with one of its peers.
Jazz Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Jazz price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Jazz using various technical indicators. When you analyze Jazz charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Jazz Pharmaceuticals Predictive Indicators
The successful prediction of Jazz Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Jazz Pharmaceuticals PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Jazz Pharmaceuticals based on analysis of Jazz Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Jazz Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Jazz Pharmaceuticals's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Inventory Turnover | 0.41 | 0.76 | 0.73 | 0.69 | ROIC | 0.0496 | 0.0334 | 0.0859 | 0.0902 |
Story Coverage note for Jazz Pharmaceuticals
The number of cover stories for Jazz Pharmaceuticals depends on current market conditions and Jazz Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Jazz Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Jazz Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Jazz Pharmaceuticals Short Properties
Jazz Pharmaceuticals' future price predictability will typically decrease when Jazz Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Jazz Pharmaceuticals PLC often depends not only on the future outlook of the potential Jazz Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Jazz Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 72.1 M | |
| Cash And Short Term Investments | 1.6 B |
Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.